You suspect an infant may have PPHN so you obtain an ECHO. Which of the following findings would suggest that your FIRST course of action should be starting inhaled pulmonary vasodilator therapy? 

Please match the terminology to the description: 

Concerning the treatment of PPHN. If you utilized a pharmacological agonist to INCREASE production of a certain hormone and powerful vasodilator of both systemic and pulmonary vascular beds, which pathway would that drug be acting on?

What perinatal risk factor is associated with PVL?

This medication is a reasonable agent to treat cardiac dysfunction in a normotensive patient with PPHN: 

Photosynthesis contributes to plant growth by ________.

The majority of infants with VACTERL have dysmorphic facial features, mental deficiency and abnormal growth. 

Premature birth occurs in the majority of VACTERL cases. 

The nurse is reviewing risk factors for DIC with the new employee. Which of the complications below put the client at risk for DIC? ( Select all that apply)

Humans are both ________.